Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Terminated NCT02824419

Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis

Conditions: Pulmonary Sarcoidosis

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: PHASE2, PHASE3

Enrollment: 5

Sponsor: Turku University Hospital

Location: Turku University Hospital Turku Southwest Finland

Summary

The goal of the current study is to evaluate the potential of the selected PET tracers to detect sarcoidotic lesions in lungs. The tracers are already in clinical use for the detection of certain inflammatory processes or malignant tumors, and their targets present similarities with molecular mechanisms of sarcoidosis.

Eligibility Criteria

Inclusion Criteria: * Patient with sarcoidosis Exclusion Criteria: * any malignant disease * any significant other inflammatory or infectious disease affecting lungs * pregnancy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT02824419). StuddyBuddy aggregates publicly available trial information.